HighGravityDataSigned in · PRO
Guidance history, every release
Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing
| Metric | Nov 7, 2024 FY24 Q3 | Feb 25, 2025 FY24 Q4 | May 1, 2025 FY25 Q1 | Aug 4, 2025 FY25 Q2 | Nov 4, 2025 FY25 Q3 | Feb 24, 2026 FY25 Q4 | May 6, 2026 FY26 Q1 | Aug 5, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2033 | ||||||||
| Moonshot goal to cut gun-related deaths between police and the public | New“50%” | Reiterated“50%” | — | — | — | — | — | — |
| For FY2028 | ||||||||
| Annual revenue | — | — | — | — | — | New“$6 billion” | — | — |
| Adjusted EBITDA margins | — | — | — | — | — | New“approximately 28%” | — | — |
| Adjusted Free Cash Flow conversion | — | — | — | — | — | New“60% of Adjusted EBITDA” | — | — |
| Annual dilution from stock-based compensation | — | — | — | — | — | New“less than 2.5%” | — | — |
| For FY2026 | ||||||||
| Revenue growth | — | — | — | — | — | — | — | New“32% to 34%” |
| Revenue growth | — | — | — | — | — | — | New“a range of 30% to 32%” | — |
| Revenue growth | — | — | — | — | — | New“27% to 30% year over year” | — | — |
| Adjusted EBITDA margin | — | — | — | — | — | — | — | New“25.5%” |
| Adjusted EBITDA margin | — | — | — | — | — | — | New“25.5%” | — |
| Adjusted EBITDA margin | — | — | — | — | — | New“25.5%” | — | — |
| Axon Body Workforce Mini early deployments (U.S. and Canada) | — | — | — | — | New“first half of 2026” | — | — | — |
| Axon Body Workforce Mini general availability | — | — | — | — | New“by mid-year” | — | — | — |
| CapEx | — | — | — | — | — | — | — | New“$160 million to $190 million” |
| CapEx | — | — | — | — | — | — | New“$160 million to $190 million” | — |
| Capital expenditures | — | — | — | — | — | New“$185 million to $215 million” | — | — |
| Five-year normalized bookings growth | — | — | — | — | — | — | — | New“greater than 30%” |
| Free cash flow | — | — | — | — | — | — | New“approximately $450 million” | — |
| Free cash flow | — | — | — | — | — | — | New“approximately $450 million” | — |
| Operating cash flow | — | — | — | — | — | — | New“over $600 million” | — |
| Operating cash flow | — | — | — | — | — | — | New“over $600 million” | — |
| Stock-based compensation expense | — | — | — | — | — | — | — | New“approximately $590 million to $620 million” |
| Stock-based compensation expense | — | — | — | — | — | — | New“approximately $590 million to $620 million” | — |
| Stock-based compensation expense | — | — | — | — | — | New“$590 million to $620 million” | — | — |
| Stock-based compensation expense related to broad-based Employee XSP and CEO Performance Award | — | — | — | — | — | — | New“approximately $230 million” | — |
| Stock-based compensation expense related to the broad-based Employee XSP and the CEO Performance Award | — | — | — | — | — | — | — | New“approximately $280 million” |
| For FY2025 | ||||||||
| Revenue | — | — | — | — | New“$750 million to $755 million” | — | — | — |
| Revenue | — | — | New“$2.60 billion to $2.70 billion” | Raised“$2.65 billion to $2.73 billion” | Raised“approximately $2.74 billion” | — | — | — |
| Revenue | — | New“$2.55 billion to $2.65 billion” | — | — | — | — | — | — |
| Revenue growth at midpoint | — | — | New“approximately 27% annual growth” | Raised“approximately 29%” | — | — | — | — |
| Adjusted EBITDA | — | — | — | — | New“$178 million to $182 million” | — | — | — |
| Adjusted EBITDA | — | New“$640 million to $670 million” | — | Raised“$665 million to $685 million” | — | — | — | — |
| Adjusted EBITDA dollars | — | — | New“$650 million to $675 million” | Raised“$665 million to $685 million” | — | — | — | — |
| Adjusted EBITDA dollars | — | New“$640 million to $670 million” | — | — | — | — | — | — |
| Adjusted EBITDA margin | — | — | — | — | New“approximately 25%” | — | — | — |
| Adjusted EBITDA margin | — | New“approximately 25%” | Reiterated“approximately 25%” | Reiterated“approximately 25%” | — | — | — | — |
| Adjusted EBITDA margin (at midpoint) | — | — | — | — | New“approximately 24% Adjusted EBITDA margin at the midpoint” | — | — | — |
| Annual growth | — | — | — | — | New“approximately 31%” | — | — | — |
| CapEx | — | — | New“$160 million to $180 million” | Raised“$170 million to $185 million” | Narrowed“$170 million to $180 million” | — | — | — |
| CapEx | — | New“$140 million to $180 million” | — | — | — | — | — | — |
| Stock-based compensation expense related to 2024 eXponential Stock Plan and 2024 CEO Performance Award | — | — | New“approximately $330 million” | — | Reiterated“approximately $330 million” | — | — | — |
| Stock-based compensation expense related to the 2024 eXponential Stock Plan and the 2024 CEO Performance Award | — | New“approximately $325 million” | — | — | — | — | — | — |
| Stock-based compensation expenses | — | New“approximately $580 million to $630 million” | Reiterated“approximately $580 million to $630 million” | Reiterated“approximately $580 million to $630 million” | Reiterated“approximately $580 million to $630 million” | — | — | — |
| For FY2024 | ||||||||
| Revenue | New“$560 million to $570 million” | — | — | — | — | — | — | — |
| Revenue expectation | New“approximately $2.07 billion” | — | — | — | — | — | — | — |
| Adjusted EBITDA | New“$130 million to $135 million” | — | — | — | — | — | — | — |
| Adjusted EBITDA | New“approximately $510 million” | — | — | — | — | — | — | — |
| Adjusted EBITDA dollars | New“approximately $510 million” | — | — | — | — | — | — | — |
| Adjusted EBITDA margin | New“approximately 23.5%” | — | — | — | — | — | — | — |
| Adjusted EBITDA margin | New“approximately 23.5%” | — | — | — | — | — | — | — |
| Adjusted EBITDA margin | New“approximately 24.6%” | — | — | — | — | — | — | — |
| CapEx | New“$80 million to $95 million” | — | — | — | — | — | — | — |
| Expected stock-based compensation expense related to the broad-based 2024 eXponential Stock Plan and the 2024 CEO Performance Award | New“Approximately $170 million” | — | — | — | — | — | — | — |
| Stock-based compensation expense for broad-based equity compensation programs and one-time enhanced equity compensation program | New“approximately $210 million” | — | — | — | — | — | — | — |
| Stock-based compensation expense related to one-time enhanced equity compensation program | New“Approximately $43 million” | — | — | — | — | — | — | — |
| Stock-based compensation expenses | New“approximately $360 million to $380 million” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Portion of total company future contracted revenue expected to be recognized over next 12 months | New“between 15% to 25%” | — | — | — | — | — | — | — |
| Software-only gross margin target | New“80%” | Reiterated“80%” | — | — | — | — | — | — |
| Fulfillment of future contracted bookings balance | — | — | — | — | — | New“between 20% and 25%” | — | — |
| Future contracted bookings expected to be fulfilled | — | — | — | — | New“between 20% to 25%” | — | — | — |
| Future Contracted Bookings expected to be fulfilled over the next 12 months | — | — | — | — | — | — | — | New“between 20% and 25%” |
| Future contracted bookings expected to be recognized | — | — | New“between 20% to 25%” | Reiterated“between 20% to 25%” | — | — | — | — |
| Portion of future contracted bookings expected to be fulfilled | — | — | — | — | — | — | New“between 20% and 25%” | — |
| Portion of future contracted bookings expected to be recognized | — | New“between 20% to 25%” | — | — | — | — | — | — |
| Remainder of future contracted bookings expected to be recognized | — | New“over the following ten years” | — | — | — | — | — | — |
| Remaining future contracted bookings expected to be fulfilled | — | — | — | — | New“the remainder to be fulfilled over the following ten years” | — | — | — |
Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.